- Home
- SDRL vs OCEAW Comparison
SDRL vs OCEAW Comparison
Compare SDRL & OCEAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDRL
- OCEAW
- Stock Information
- Founded
- SDRL 2005
- OCEAW N/A
- Country
- SDRL Bermuda
- OCEAW United States
- Employees
- SDRL N/A
- OCEAW 7
- Industry
- SDRL Oil & Gas Production
- OCEAW Biotechnology: Pharmaceutical Preparations
- Sector
- SDRL Energy
- OCEAW Health Care
- Exchange
- SDRL Nasdaq
- OCEAW Nasdaq
- Market Cap
- SDRL N/A
- OCEAW N/A
- IPO Year
- SDRL N/A
- OCEAW 2021
- Fundamental
- Price
- SDRL $20.88
- OCEAW $0.02
- Analyst Decision
- SDRL Strong Buy
- OCEAW
- Analyst Count
- SDRL 6
- OCEAW 0
- Target Price
- SDRL $59.60
- OCEAW N/A
- AVG Volume (30 Days)
- SDRL 1.3M
- OCEAW N/A
- Earning Date
- SDRL 05-13-2025
- OCEAW N/A
- Dividend Yield
- SDRL N/A
- OCEAW N/A
- EPS Growth
- SDRL 54.46
- OCEAW N/A
- EPS
- SDRL 6.37
- OCEAW N/A
- Revenue
- SDRL $1,315,000,000.00
- OCEAW N/A
- Revenue This Year
- SDRL $5.55
- OCEAW N/A
- Revenue Next Year
- SDRL $16.86
- OCEAW N/A
- P/E Ratio
- SDRL $3.28
- OCEAW N/A
- Revenue Growth
- SDRL N/A
- OCEAW N/A
- 52 Week Low
- SDRL $17.74
- OCEAW N/A
- 52 Week High
- SDRL $56.46
- OCEAW N/A
- Technical
- Relative Strength Index (RSI)
- SDRL 43.20
- OCEAW N/A
- Support Level
- SDRL $18.61
- OCEAW N/A
- Resistance Level
- SDRL $20.63
- OCEAW N/A
- Average True Range (ATR)
- SDRL 1.77
- OCEAW 0.00
- MACD
- SDRL -0.00
- OCEAW 0.00
- Stochastic Oscillator
- SDRL 38.57
- OCEAW 0.00
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.